Keyphrases
Ferric Citrate
100%
Anemia Management
100%
Drug Dependence
100%
Cost Reduction
100%
Intravenous Iron
83%
Erythropoiesis-stimulating Agents
83%
End-stage Renal Disease
66%
Total Annual Cost
50%
Base Rates
50%
Phosphate Binder
33%
Regent
16%
Hemodialysis Patients
16%
Monte Carlo Uncertainty Analysis
16%
Amgen
16%
Actual Use
16%
Number of Outpatients
16%
Health Care Costs
16%
Sanofi
16%
Monte Carlo Analysis
16%
Epogen
16%
United States Renal Data System (USRDS)
16%
Aranesp
16%
Venofer
16%
Healthcare Analytics
16%
Ferrlecit
16%
Healthcare Cost Savings
16%
US Health Care
16%
Nursing and Health Professions
Anemia
100%
Ferric Citrate
100%
Central Stimulant Agent
83%
Erythropoietin
83%
Iron
83%
End Stage Renal Disease
66%
Base
50%
Medicare
50%
Health Care Cost
33%
Procrit
33%
Phosphate Binding Agent
33%
Outpatient
16%
Cost Control
16%
Ferric Gluconate
16%
Iron Saccharate
16%
Pharmacology, Toxicology and Pharmaceutical Science
Ferric Citrate
100%
Stimulant
83%
Erythropoietin
83%
Iron
83%
End Stage Renal Disease
66%
Hemodialysis
50%
Phosphate Binding Agent
33%
Recombinant Erythropoietin
33%
Ferric Gluconate
16%
Iron Saccharate
16%
Medicine and Dentistry
Ferric Citrate
100%
Erythropoietin
50%
Iron
50%
End Stage Renal Disease
40%
Recombinant Erythropoietin
20%
Phosphate Binder
20%
Iron Sucrose
10%
Outpatient
10%
Ferric Gluconate
10%
Agricultural and Biological Sciences
Erythropoietin
100%
Uncertainty Analysis
20%